Search clinical trials for: relapsed multiple myeloma

Total 17279 results

Gruppo Italiano Multiregionale per lo studio dei...
University of Turin, Italy; Fondazione Italiana Linfomi ONLUS; Centro di Riferimento...

Completed

Non-randomized Safety Study With Bortezomib/Rituximab in Relapsed/Refractory Indolent Lymphoma (LYM-2023)

Lymphoma | Non-Hodgkin Lymphoma

Italy
Bristol-Myers Squibb

Completed

Multiple Dose Study In Treatment Naive Subjects Infected With Hepatitis C Virus

Chronic Hepatitis C

United States
Bristol-Myers Squibb

Completed

Multiple Dose Japanese Bridging Study

Alzheimer Disease

United States
Bristol-Myers Squibb

Completed

Multiple Ascending Dose Study of BMS-777607 in Subjects With Advanced or Metastatic Solid Tumors

Advanced Solid Tumors

Australia
AstraZeneca

Terminated

Phase I, Open-label, Dose Escalation of AZD4877 in Hematologic Malignancies

Lymphoma

United States, Canada
AstraZeneca

Completed

Phase I AZD2171 in Patients With Relapsed or Refractory AML and Elderly Patients With DeNovo or Secondary AML

Acute | Leukaemia | Myelocytic
AstraZeneca

Completed

Study to Assess Safety and Tolerability of AZD2171 After Multiple Doses in Patients With Advanced Prostate Cancer (AZD2171IL/0003)

Advanced Prostate Adenocarcinoma

United States
Pfizer

Completed

A Study To Observe Safety And Blood Concentrations Of PF-04995274 During And Following the Administration of Multiple Doses Of PF-04995274 In Healthy Adult And Healthy Elderly Volunteers.

Healthy

United States
CellMed AG, a subsidiary of BTG plc.

Completed

Clinical Study to Investigate Safety and Tolerability and Pharmacokinetics of Multiple Ascending Doses of CM3.1-AC100 in Healthy Male Volunteers

Healthy

Germany
Novartis

Completed

Safety and Pharmacokinetics of LHT344 in Chinese Healthy Subjects

Healthy

China
Pfizer

Completed

Multiple Dose Healthy Volunteer Study of PF-03715455. (MD-MULTI DOSE)

Healthy Volunteers

Singapore
Glostrup University Hospital, Copenhagen
Alpharma ApS

Unknown

Simvastatin Treatment of Patients With Acute Optic Neuritis

Multiple Sclerosis | Optic Neuritis

Denmark
Johnson & Johnson Pharmaceutical Research & Development...
Eisai Inc.

Completed

A Pharmacokinetic and Safety Study of Single and Multiple Doses of Rabreprazole in Pediatric Patients With Gastroesophageal Reflux Disease (GERD) 1 to 11 Years Old, Inclusive

GERD
Bristol-Myers Squibb

Completed

Multiple Ascending Dose Study of BMS-907351 (XL184) in Patients With Solid Tumors in Japan

Neoplasms

Japan
Bristol-Myers Squibb

Completed

Safety Study of Multiple-dose of Gamma-secretase Inhibitor in Healthy Male Japanese and Healthy Elderly Japanese (JMAD)

Healthy

Japan
Pfizer

Terminated

Multiple Dose Study To Investigate The Effects Of Fesoterodine And Solifenacin On Gastrointestinal Transit

Healthy

United States
Pfizer
ViiV Healthcare

Completed

Study To Evaluate The Effect Of A Multiple Oral Dose Of PF-00232798 On QT Intervals In Healthy Subjects

Healthy

Singapore
TauRx Therapeutics Ltd
Quotient Clinical

Completed

Multiple Dose Study of TRx0037

Alzheimer's Disease
AstraZeneca

Completed

Multiple Ascending Dose Study for AZD 7268 in Japanese Healthy Male Volunteers (JMAD)

Healthy

Japan
Bristol-Myers Squibb

Completed

Study of Dasatinib (BMS-354825) in Patients With Solid Tumors

Tumors

Japan
AstraZeneca

Completed

Study to Investigate the Safety, Tolerability and Pharmacokinetics of AZD1386 (MAD)

Chronic Pain

United Kingdom
AstraZeneca

Completed

AZD6280 Multiple Ascending Dose Study (MAD)

Healthy Volunteer

United States
City of Hope Medical Center

Terminated

Vorinostat and Lenalidomide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma

Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditions

United States
AstraZeneca

Completed

AZD7325 Multiple Ascending Dose Study (MAD)

Healthy Volunteer

United States
AstraZeneca

Completed

Safety, Tolerability, PK and Efficacy of AZD1152 in Patients With Relapsed Acute Myeloid Leukemia

Myeloid Leukemia

United States, Italy, Netherlands, France
AstraZeneca

Completed

To Investigate the Safety and Tolerability of TC-5214 Following Oral Administration of Multiple Doses for up to 8 Days

Healthy

United States
AstraZeneca

Terminated

AZD1305 Single and Multiple Ascending Dose Study in Healthy Japanese and Caucasian Subjects (JMAD)

Healthy

United States
Bristol-Myers Squibb

Terminated

A Study to Evaluate the Preliminary Efficacy Pharmacokinetics and Immunogenicity of BMS-188667 Administered to Subjects With Relapsing-remitting Multiple Sclerosis

Multiple Sclerosis

United States
AstraZeneca

Completed

To Evaluate Safety and Tolerability After Multiple Oral Doses of AZD1656 in Type 2 Diabetes Patients on Top of Insulin

Type 2 Diabetes

United States
AstraZeneca

Completed

Study of an Extended Release (ER) Tablet, Single and Repeated Dosing

Healthy

Sweden
AstraZeneca

Terminated

A Single and Multiple Ascending Dose Study With AZD9164 Given for 13 Days in Healthy Male and Female Japanese Subjects (JSMAD)

Healthy

United Kingdom
SterilMed, Inc.

Completed

Pulse Oximeter Responses to Multiple Levels of Stable Hypoxia in Neonates

Hypoxia
AstraZeneca

Completed

An Open-Label, Single and Multiple Dose Pharmacokinetic Study of 90 mg and 180 mg Doses of AZD6140 in Healthy Volunteers

Pharmacokinetics

China
SterilMed, Inc.

Completed

Pulse Oximeter Responses to Multiple Levels of Stable Hypoxia

Hypoxia
AstraZeneca

Completed

A Study to Evaluate Safety, Tolerability and P-Glucose After Multiple Ascending Oral Doses of AZD1656 in Type 2 Diabetes (MAD)

Type 2 Diabetes

United States
AstraZeneca

Completed

Single and Multiple Ascending Doses of AZD1981 in Japan (JSAD/JMAD)

Healthy

United Kingdom
Cantonal Hospital of St. Gallen
Biogen

Unknown

Neurocognitive Changes in Patients With Remitting Relapsing Multiple Sclerosis Treated With Natalizumab

Multiple Sclerosis | Cognitive Impairment

Switzerland
Baylor College of Medicine

Unknown

A Comparison of Two Target Mean Arterial Pressures in the Resuscitation of Hypotensive Trauma Patients

Trauma | Hemorrhagic Shock | Multiple Trauma | Wounds, Penetrating | Shock, Traumatic

United States
AstraZeneca

Withdrawn

Assessment of the Safety and Pharmacokinetics of Single and Multiple Oral Doses of AZD4316 in Healthy Subjects

Healthy Volunteers

United Kingdom
Cantonal Hospital of St. Gallen
Bayer

Unknown

Study Comparing Corpus Callosum Atrophy as a Marker of Later Development of Cognitive Impairment in Patients With Multiple Sclerosis

Multiple Sclerosis | Cognitive Impairment

Switzerland
Pfizer

Terminated

Single and Multiple Dose Safety, Tolerability, and Pharmacokinetics Study of PF-04805712 in Healthy Volunteers

Healthy Volunteers

Singapore
AstraZeneca

Terminated

A Multiple Ascending Dose Study With AZD9164 Given for 13 Days in Healthy Male and Female Subjects and in Patients With Chronic Obstructive Pulmonary Disease

Healthy | COPD

Sweden
Tehran University of Medical Sciences

Unknown

Relationship Between Erythropoietin Administration and Stress Responses in Trauma Patients (EPREX)

Multiple Trauma

Iran, Islamic Republic of
Azienda Ospedaliera San Camillo Forlanini

Completed

Comparison of Endothelial Dysfunction (BMS vs SES) in the Same Patient With Multiple Coronary Artery Lesions (CREDENTIAL)

Endothelial Dysfunction

Italy
AstraZeneca

Completed

Faslodex 500mg Multiple Dose Tolerability Study in BC Patients

Advanced Breast Cancer

Japan
NMP Medical Research Institute

Completed

Homeopathy as an Adjuvant to Chemotherapy Improves Clinical Outcome in Relapsed Pulmonary Tuberculosis

Pulmonary Tuberculosis

India
Harvard School of Public Health (HSPH)
Muhimbili University of Health and Allied Sciences

Completed

Multivitamin Dosage Regimens in the Prevention of Adverse Pregnancy Outcomes Among HIV-Positive Women

HIV Infections

United States
Galmed Medical Reserch

Completed

A Phase 1 Single and Multiple-Dose Study of Aramchol in Healthy Male Volunteers

Healthy

Israel
Abbott

Completed

A Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of ABT-436 in Healthy Adults

Healthy

United States
Zealand Pharma

Completed

Healthy Normal Single Ascending Dose and Crohn's Patient Multiple Ascending Dose

Inflammatory Bowel Disease

United States

3

Subscribe